Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study.

Bressler J, Mosley TH, Penman A, Gottesman RF, Windham BG, Knopman DS, Wruck LM, Boerwinkle E.

Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):269-282. doi: 10.1002/ajmg.b.32509. Epub 2016 Oct 26.

2.

Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.

Bressler J, Yu B, Mosley TH, Knopman DS, Gottesman RF, Alonso A, Sharrett AR, Wruck LM, Boerwinkle E.

Transl Psychiatry. 2017 Jul 18;7(7):e1173. doi: 10.1038/tp.2017.118.

3.

Fat mass and obesity gene and cognitive decline: the Atherosclerosis Risk in Communities Study.

Bressler J, Fornage M, Demerath EW, Knopman DS, Monda KL, North KE, Penman A, Mosley TH, Boerwinkle E.

Neurology. 2013 Jan 1;80(1):92-9. doi: 10.1212/WNL.0b013e3182768910. Epub 2012 Nov 7.

4.

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.

Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, Smith GE, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Alzheimers Dement. 2014 Mar;10(2):205-13. doi: 10.1016/j.jalz.2013.01.016. Epub 2013 May 2.

5.

Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.

Nordestgaard LT, Tybjærg-Hansen A, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R.

BMC Med. 2018 Mar 14;16(1):39. doi: 10.1186/s12916-018-1029-3.

6.

Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.

Ebbert MTW, Boehme KL, Wadsworth ME, Staley LA; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Genetics Consortium, Mukherjee S, Crane PK, Ridge PG, Kauwe JSK.

Alzheimers Dement. 2016 Feb;12(2):121-129. doi: 10.1016/j.jalz.2015.08.163. Epub 2015 Oct 9.

7.

Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study.

Schneider AL, Lutsey PL, Alonso A, Gottesman RF, Sharrett AR, Carson KA, Gross M, Post WS, Knopman DS, Mosley TH, Michos ED.

Eur J Neurol. 2014 Sep;21(9):1211-8, e69-70. doi: 10.1111/ene.12460. Epub 2014 May 21.

8.

Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.

Andrews SJ, Das D, Anstey KJ, Easteal S.

J Alzheimers Dis. 2017;57(2):423-436. doi: 10.3233/JAD-160774.

PMID:
28269768
9.

APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.

Hendrie HC, Murrell J, Baiyewu O, Lane KA, Purnell C, Ogunniyi A, Unverzagt FW, Hall K, Callahan CM, Saykin AJ, Gureje O, Hake A, Foroud T, Gao S.

Int Psychogeriatr. 2014 Jun;26(6):977-85. doi: 10.1017/S1041610214000167. Epub 2014 Feb 24.

10.

High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.

Schneider AL, Rawlings AM, Sharrett AR, Alonso A, Mosley TH, Hoogeveen RC, Ballantyne CM, Gottesman RF, Selvin E.

Eur Heart J. 2014 Jul 14;35(27):1817-24. doi: 10.1093/eurheartj/ehu124. Epub 2014 Mar 30.

11.

Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, Coresh J, Knopman D, Power MC, Rawlings A, Sharrett AR, Wruck LM, Mosley TH.

JAMA Neurol. 2014 Oct;71(10):1218-27. doi: 10.1001/jamaneurol.2014.1646.

12.

Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study.

Vivot A, Glymour MM, Tzourio C, Amouyel P, Chêne G, Dufouil C.

Mol Psychiatry. 2015 Oct;20(10):1173-8. doi: 10.1038/mp.2015.62. Epub 2015 Jun 2.

PMID:
26033242
13.

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.

Lacour A, Espinosa A, Louwersheimer E, Heilmann S, Hernández I, Wolfsgruber S, Fernández V, Wagner H, Rosende-Roca M, Mauleón A, Moreno-Grau S, Vargas L, Pijnenburg YA, Koene T, Rodríguez-Gómez O, Ortega G, Ruiz S, Holstege H, Sotolongo-Grau O, Kornhuber J, Peters O, Frölich L, Hüll M, Rüther E, Wiltfang J, Scherer M, Riedel-Heller S, Alegret M, Nöthen MM, Scheltens P, Wagner M, Tárraga L, Jessen F, Boada M, Maier W, van der Flier WM, Becker T, Ramirez A, Ruiz A.

Mol Psychiatry. 2017 Jan;22(1):153-160. doi: 10.1038/mp.2016.18. Epub 2016 Mar 15.

14.

Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study.

Simino J, Wang Z, Bressler J, Chouraki V, Yang Q, Younkin SG, Seshadri S, Fornage M, Boerwinkle E, Mosley TH Jr.

PLoS One. 2017 Jul 13;12(7):e0180046. doi: 10.1371/journal.pone.0180046. eCollection 2017.

15.

Alzheimer's disease genes and cognition in the nondemented general population.

Verhaaren BF, Vernooij MW, Koudstaal PJ, Uitterlinden AG, van Duijn CM, Hofman A, Breteler MM, Ikram MA.

Biol Psychiatry. 2013 Mar 1;73(5):429-34. doi: 10.1016/j.biopsych.2012.04.009. Epub 2012 May 15.

PMID:
22592056
16.

Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study.

Mosley TH Jr, Knopman DS, Catellier DJ, Bryan N, Hutchinson RG, Grothues CA, Folsom AR, Cooper LS, Burke GL, Liao D, Szklo M.

Neurology. 2005 Jun 28;64(12):2056-62.

PMID:
15985571
17.

Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study.

Schneider AL, Jonassaint C, Sharrett AR, Mosley TH, Astor BC, Selvin E, Coresh J, Gottesman RF.

J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):772-9. doi: 10.1093/gerona/glv158. Epub 2015 Sep 11.

18.

Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.

Rodríguez-Rodríguez E, Sánchez-Juan P, Vázquez-Higuera JL, Mateo I, Pozueta A, Berciano J, Cervantes S, Alcolea D, Martínez-Lage P, Clarimón J, Lleó A, Pastor P, Combarros O.

J Neural Transm (Vienna). 2013 May;120(5):807-12. doi: 10.1007/s00702-012-0920-x. Epub 2012 Nov 20.

PMID:
23180304
19.

ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan.

Liao YC, Lee WJ, Hwang JP, Wang YF, Tsai CF, Wang PN, Wang SJ, Fuh JL.

Neurobiol Aging. 2014 Oct;35(10):2423.e7-2423.e13. doi: 10.1016/j.neurobiolaging.2014.05.009. Epub 2014 May 14.

PMID:
24908168
20.

Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults.

Sawyer K, Sachs-Ericsson N, Preacher KJ, Blazer DG.

Gerontology. 2009;55(1):32-40. doi: 10.1159/000137666. Epub 2008 Jun 5.

PMID:
18525196

Supplemental Content

Support Center